Gene · 7075
Papers2,045
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,045
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Angiopoietin-Like Protein 2 Is Increased in Obese Mouse Models of Lung Injury. | Comput Math Methods Med | 2022 | 36176743 | PubTator, text mining | PubMed |
| Prognostic value of LECT2 and relevance to immune infiltration in hepatocellular carcinoma. | Front Genet | 2022 | 36160006 | PubTator, text mining | PubMed |
| Post-phagocytosis activation of NLRP3 inflammasome by two novel T6SS effectors. | Elife | 2022 | 36155655 | PubTator, text mining | PubMed |
| Endothelial caveolin-1 regulates cerebral thrombo-inflammation in acute ischemia/reperfusion injury. | EBioMedicine | 2022 | 36152520 | PubTator, text mining | PubMed |
| SARS-CoV-2 Spike protein promotes vWF secretion and thrombosis via endothelial cytoskeleton-associated protein 4 (CKAP4). | Signal Transduct Target Ther | 2022 | 36138024 | PubTator, text mining | PubMed |
| Pulmonary Vascular Sequelae of Palliated Single Ventricle Circulation: Arteriovenous Malformations and Aortopulmonary Collaterals. | J Cardiovasc Dev Dis | 2022 | 36135454 | PubTator, text mining | PubMed |
| Circulating Angiogenic Markers in Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review. | Curr Issues Mol Biol | 2022 | 36135186 | PubTator, text mining | PubMed |
| Molecular mechanisms of resistance to tyrosine kinase inhibitor in clear cell renal cell carcinoma. | Int J Urol | 2022 | 36122306 | PubTator, text mining | PubMed |
| Tumor vessel co-option: The past & the future. | Front Oncol | 2022 | 36119528 | PubTator, text mining | PubMed |
| Fetal nuchal edema and developmental anomalies caused by gene mutations in mice. | Front Cell Dev Biol | 2022 | 36111337 | PubTator, text mining | PubMed |
| The road of NSCLC stem cells toward bone metastases. | Bone Rep | 2022 | 36110341 | PubTator, text mining | PubMed |
| Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors. | ESMO Open | 2022 | 36108560 | PubTator, text mining | PubMed |
| Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma. | Front Genet | 2022 | 36092911 | PubTator, text mining | PubMed |
| Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies. | Mol Ther Oncolytics | 2022 | 36090475 | PubTator, text mining | PubMed |
| Arabidopsis TIE1 and TIE2 transcriptional repressors dampen cytokinin response during root development. | Sci Adv | 2022 | 36083905 | PubTator, text mining | PubMed |
| Mechanical regulation of signal transduction in angiogenesis. | Front Cell Dev Biol | 2022 | 36081909 | PubTator, text mining | PubMed |
| Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges. | Molecules | 2022 | 36080304 | PubTator, text mining | PubMed |
| Melanoma Tumour Vascularization and Tissue-Resident Endothelial Progenitor Cells. | Cancers (Basel) | 2022 | 36077754 | PubTator, text mining | PubMed |
| Single-Chain Fragment Variable: Recent Progress in Cancer Diagnosis and Therapy. | Cancers (Basel) | 2022 | 36077739 | PubTator, text mining | PubMed |
| Identification of Gender- and Subtype-Specific Gene Expression Associated with Patient Survival in Low-Grade and Anaplastic Glioma in Connection with Steroid Signaling. | Cancers (Basel) | 2022 | 36077653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7075/papers?page=19